Data from Israel: Myocarditis after COVID-19 vaccines remain rare, highest risk in young males
Seminar series offers deep dive on exercise and the heart
5 September 2022Low-dose steroids: Helping babies come off ventilators and preserving the heart at the same time
6 September 2022Data from Israel: Myocarditis after COVID-19 vaccines remain rare, highest risk in young males
A new study from Israel found that the risk of developing myocarditis among males ages 16 to 19 years was about 1 in 15,000 after a third dose of the Pfizer-BioNTech COVID-19 vaccine, and the cases were rare and mild, according to new research published today in Circulation.
